aHUS Trials Watch 11 ( Crovalimab)

Article No. 415 1 February 2021 In a recent article (article413) about research into why specifically  monoclonal antibodies (mAb) work when blockading Complement Protein C5 , a novel mAb called…

Continue Reading aHUS Trials Watch 11 ( Crovalimab)

aHUS and COVID19 vaccinations

Article No. 411 16 January 2021 COVID 19 dominates healthcare throughout the world. It dominates politics. It is in the news, it is in the social media , it is…

Continue Reading aHUS and COVID19 vaccinations

Atypical HUS: Not Like the Others

Patient involvement needs to be integrated across all areas of research and at early stages of planning clinical trials. When patient engagement is in the atypical HUS arena, what considerations make outreach a bit different for advocacy regarding this ultra rare disease?

Continue Reading Atypical HUS: Not Like the Others

2020 aHUS Awareness Day

Article No. 361 24 July 2020   The world’s 6th annual aHUS Awareness Day, to be held on Thursday 24 September 2020, was created by the aHUS Alliance to share…

Continue Reading 2020 aHUS Awareness Day

aHUS in Deutschland

Article No. 349 14 June 2020 Die aHUS Global Action-Website hat mehrere nicht englische Artikel über aHUS aus der ganzen Welt veröffentlicht. Als einzige Gobal-Website über aHUS möchten wir mehr…

Continue Reading aHUS in Deutschland

What about aHUS?

Article No. 348 10 June 2020 A few weeks ago saw an anniversary of the launch of this website. Not a big deal really.  Just over four years ago a…

Continue Reading What about aHUS?

aHUS is….

Article No. 345 20 May 2020 COVID 19 lockdown does seem to give more time to think about things, so the question "What is aHUS?" has been pondered to fill…

Continue Reading aHUS is….